UA92304U - Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitus - Google Patents
Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitusInfo
- Publication number
- UA92304U UA92304U UAU201402454U UAU201402454U UA92304U UA 92304 U UA92304 U UA 92304U UA U201402454 U UAU201402454 U UA U201402454U UA U201402454 U UAU201402454 U UA U201402454U UA 92304 U UA92304 U UA 92304U
- Authority
- UA
- Ukraine
- Prior art keywords
- raleukine
- interleukin
- antagonist
- insulin
- receptor
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 102000019223 Interleukin-1 receptor Human genes 0.000 title abstract 2
- 108050006617 Interleukin-1 receptor Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229940125708 antidiabetic agent Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The use of Raleukine (antagonist of interleukin-1 receptor) as antidiabetic agent in therapy of insulin-independent diabetes mellitus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201402454U UA92304U (en) | 2014-03-12 | 2014-03-12 | Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201402454U UA92304U (en) | 2014-03-12 | 2014-03-12 | Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA92304U true UA92304U (en) | 2014-08-11 |
Family
ID=52682413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201402454U UA92304U (en) | 2014-03-12 | 2014-03-12 | Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitus |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA92304U (en) |
-
2014
- 2014-03-12 UA UAU201402454U patent/UA92304U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291922B1 (en) | Fap-activated therapeutic agents, and uses related thereto | |
| ZA201904616B (en) | Glp-1 receptor agonists and uses thereof | |
| SG11201610729XA (en) | Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors | |
| MX384192B (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| EP3108287A4 (en) | Head mounted display goggles for use with mobile computing devices | |
| IL249896B (en) | Glp-1 receptor modulators and use thereof as medicaments | |
| MX365458B (en) | Glucagon/glp-1 agonists for the treatment of obesity. | |
| HK1220383A1 (en) | Pegylated glucagon and glp-1 co-agonists for the treatment of obesity | |
| ZA202507395B (en) | Semaglutide in cardiovascular conditions | |
| DK3150578T3 (en) | Novel pyrrolidine compound and use as melanocortin receptor agonist | |
| WO2017100107A3 (en) | Co-agonists of the glucagon and glp-1 receptors | |
| PH12016502331A1 (en) | Novel compounds | |
| EP3132272A4 (en) | Processor chip with ultrasound transducer for ultrasound chip debugging | |
| IL242748B (en) | Nmdar agonists for use in the treatment of autoimmune-induced glutamatergic receptor dysfunction | |
| CA3013532A1 (en) | Liraglutide in cardiovascular conditions | |
| UA92304U (en) | Use of raleukine (antagonist of interleukin-1 receptor) in therapy of insulin-independent diabetes mellitus | |
| ZA201701714B (en) | Anthostema senegalense-based composition, for use as an anti-aids drug | |
| EP3125919A4 (en) | Chemokine receptor antagonist and its combinational therapy | |
| UA88242U (en) | Use of raleukin (antagonist of interleukin-1 receptor) as hypoglycemic agent | |
| HK1234739A1 (en) | Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors | |
| HK1235411A1 (en) | Co-agonists of the glucagon and glp-1 receptors | |
| HK1231767A1 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| AU2014900135A0 (en) | Measurement device for use with applanation tonometer | |
| PH32015000621S1 (en) | Chair (olympia chair with armrest) | |
| HK1236210A1 (en) | Insulin receptor partial agonists |